nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—SLC10A1—Ethinyl Estradiol—prostate cancer	0.0632	0.0943	CbGbCtD
Liotrix—SLCO4A1—Conjugated Estrogens—prostate cancer	0.0584	0.0871	CbGbCtD
Liotrix—SLCO4A1—Estradiol—prostate cancer	0.0512	0.0765	CbGbCtD
Liotrix—SLC10A1—Conjugated Estrogens—prostate cancer	0.0464	0.0692	CbGbCtD
Liotrix—SLCO1C1—Conjugated Estrogens—prostate cancer	0.041	0.0612	CbGbCtD
Liotrix—SLCO1C1—Estradiol—prostate cancer	0.036	0.0537	CbGbCtD
Liotrix—SLCO1B3—Cabazitaxel—prostate cancer	0.0358	0.0534	CbGbCtD
Liotrix—SLCO1B3—Conjugated Estrogens—prostate cancer	0.0229	0.0342	CbGbCtD
Liotrix—SLCO1A2—Estrone—prostate cancer	0.0216	0.0322	CbGbCtD
Liotrix—SLCO1B1—Cabazitaxel—prostate cancer	0.0208	0.0311	CbGbCtD
Liotrix—SLCO1B1—Estrone—prostate cancer	0.0204	0.0304	CbGbCtD
Liotrix—SLCO1B3—Estradiol—prostate cancer	0.0201	0.03	CbGbCtD
Liotrix—ALB—Abiraterone—prostate cancer	0.0154	0.023	CbGbCtD
Liotrix—CYP2C8—Nilutamide—prostate cancer	0.0144	0.0215	CbGbCtD
Liotrix—SLCO1A2—Conjugated Estrogens—prostate cancer	0.0141	0.0211	CbGbCtD
Liotrix—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0133	0.0199	CbGbCtD
Liotrix—SLCO1A2—Estradiol—prostate cancer	0.0124	0.0185	CbGbCtD
Liotrix—SLC22A8—Conjugated Estrogens—prostate cancer	0.0123	0.0184	CbGbCtD
Liotrix—SLCO1B3—Docetaxel—prostate cancer	0.012	0.0179	CbGbCtD
Liotrix—CYP2C8—Abiraterone—prostate cancer	0.0119	0.0178	CbGbCtD
Liotrix—SLCO1B1—Estradiol—prostate cancer	0.0117	0.0175	CbGbCtD
Liotrix—ALB—Estrone—prostate cancer	0.0112	0.0167	CbGbCtD
Liotrix—SLC22A8—Estradiol—prostate cancer	0.0108	0.0161	CbGbCtD
Liotrix—SLCO1A2—Prednisone—prostate cancer	0.0107	0.0159	CbGbCtD
Liotrix—ABCB1—Estramustine—prostate cancer	0.00906	0.0135	CbGbCtD
Liotrix—CYP2C8—Cabazitaxel—prostate cancer	0.00882	0.0132	CbGbCtD
Liotrix—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00769	0.0115	CbGbCtD
Liotrix—ALB—Estradiol—prostate cancer	0.00641	0.00957	CbGbCtD
Liotrix—ABCB1—Cabazitaxel—prostate cancer	0.00597	0.00892	CbGbCtD
Liotrix—ABCB1—Estrone—prostate cancer	0.00584	0.00871	CbGbCtD
Liotrix—ALB—Prednisone—prostate cancer	0.00551	0.00823	CbGbCtD
Liotrix—ABCB1—Ethinyl Estradiol—prostate cancer	0.0052	0.00777	CbGbCtD
Liotrix—CYP2C8—Estradiol—prostate cancer	0.00495	0.00739	CbGbCtD
Liotrix—TTR—urine—prostate cancer	0.00425	0.0803	CbGeAlD
Liotrix—ABCB1—Conjugated Estrogens—prostate cancer	0.00382	0.0057	CbGbCtD
Liotrix—ABCB1—Mitoxantrone—prostate cancer	0.00347	0.00518	CbGbCtD
Liotrix—ABCB1—Estradiol—prostate cancer	0.00335	0.005	CbGbCtD
Liotrix—CYP2C8—Etoposide—prostate cancer	0.00323	0.00483	CbGbCtD
Liotrix—ABCB1—Prednisone—prostate cancer	0.00288	0.0043	CbGbCtD
Liotrix—SLC22A8—urine—prostate cancer	0.00261	0.0492	CbGeAlD
Liotrix—ABCB1—Etoposide—prostate cancer	0.00219	0.00327	CbGbCtD
Liotrix—THRB—prostate gland—prostate cancer	0.00205	0.0388	CbGeAlD
Liotrix—THRA—prostate gland—prostate cancer	0.00205	0.0388	CbGeAlD
Liotrix—ABCB1—Docetaxel—prostate cancer	0.002	0.00299	CbGbCtD
Liotrix—SLC16A2—prostate gland—prostate cancer	0.00186	0.0351	CbGeAlD
Liotrix—SLC10A1—prostate gland—prostate cancer	0.00182	0.0343	CbGeAlD
Liotrix—SLCO4C1—seminal vesicle—prostate cancer	0.00181	0.0342	CbGeAlD
Liotrix—SERPINA7—bone marrow—prostate cancer	0.00171	0.0323	CbGeAlD
Liotrix—SLC10A1—seminal vesicle—prostate cancer	0.00154	0.029	CbGeAlD
Liotrix—ABCB1—Doxorubicin—prostate cancer	0.00149	0.00223	CbGbCtD
Liotrix—SLCO4C1—renal system—prostate cancer	0.00146	0.0276	CbGeAlD
Liotrix—THRA—renal system—prostate cancer	0.0014	0.0264	CbGeAlD
Liotrix—THRB—renal system—prostate cancer	0.0014	0.0264	CbGeAlD
Liotrix—SLCO4A1—prostate gland—prostate cancer	0.00137	0.0258	CbGeAlD
Liotrix—SLC16A2—urethra—prostate cancer	0.00125	0.0235	CbGeAlD
Liotrix—SLC10A1—renal system—prostate cancer	0.00124	0.0234	CbGeAlD
Liotrix—SLC16A10—prostate gland—prostate cancer	0.0012	0.0227	CbGeAlD
Liotrix—SLCO1C1—renal system—prostate cancer	0.00116	0.022	CbGeAlD
Liotrix—SLCO4A1—seminal vesicle—prostate cancer	0.00116	0.0219	CbGeAlD
Liotrix—SLCO4C1—bone marrow—prostate cancer	0.0011	0.0208	CbGeAlD
Liotrix—TTR—renal system—prostate cancer	0.00104	0.0196	CbGeAlD
Liotrix—SLC22A8—prostate gland—prostate cancer	0.000935	0.0177	CbGeAlD
Liotrix—SLCO4A1—renal system—prostate cancer	0.000932	0.0176	CbGeAlD
Liotrix—SLCO4A1—urethra—prostate cancer	0.000916	0.0173	CbGeAlD
Liotrix—THRB—testis—prostate cancer	0.000904	0.0171	CbGeAlD
Liotrix—THRA—testis—prostate cancer	0.000904	0.0171	CbGeAlD
Liotrix—SLC16A10—epithelium—prostate cancer	0.000881	0.0166	CbGeAlD
Liotrix—SLCO1B1—renal system—prostate cancer	0.00082	0.0155	CbGeAlD
Liotrix—SLC16A2—testis—prostate cancer	0.000819	0.0155	CbGeAlD
Liotrix—SLC10A1—testis—prostate cancer	0.0008	0.0151	CbGeAlD
Liotrix—TTR—bone marrow—prostate cancer	0.000786	0.0149	CbGeAlD
Liotrix—SLCO1C1—testis—prostate cancer	0.000752	0.0142	CbGeAlD
Liotrix—TTR—testis—prostate cancer	0.000672	0.0127	CbGeAlD
Liotrix—SLCO1A2—renal system—prostate cancer	0.000668	0.0126	CbGeAlD
Liotrix—THRA—lymph node—prostate cancer	0.000656	0.0124	CbGeAlD
Liotrix—THRB—lymph node—prostate cancer	0.000656	0.0124	CbGeAlD
Liotrix—SLC22A8—renal system—prostate cancer	0.000637	0.012	CbGeAlD
Liotrix—SLCO4A1—testis—prostate cancer	0.000603	0.0114	CbGeAlD
Liotrix—SLC16A2—lymph node—prostate cancer	0.000594	0.0112	CbGeAlD
Liotrix—SLCO1C1—lymph node—prostate cancer	0.000545	0.0103	CbGeAlD
Liotrix—SLC16A10—testis—prostate cancer	0.000528	0.00998	CbGeAlD
Liotrix—CYP2C8—renal system—prostate cancer	0.000466	0.00881	CbGeAlD
Liotrix—SLCO4A1—lymph node—prostate cancer	0.000437	0.00825	CbGeAlD
Liotrix—SLCO1A2—testis—prostate cancer	0.000431	0.00815	CbGeAlD
Liotrix—ALB—testis—prostate cancer	0.000429	0.0081	CbGeAlD
Liotrix—SLC16A10—lymph node—prostate cancer	0.000383	0.00723	CbGeAlD
Liotrix—ABCB1—prostate gland—prostate cancer	0.000328	0.0062	CbGeAlD
Liotrix—ALB—lymph node—prostate cancer	0.000311	0.00587	CbGeAlD
Liotrix—CYP2C8—testis—prostate cancer	0.000301	0.00569	CbGeAlD
Liotrix—ABCB1—seminal vesicle—prostate cancer	0.000278	0.00524	CbGeAlD
Liotrix—ABCB1—epithelium—prostate cancer	0.000241	0.00455	CbGeAlD
Liotrix—ABCB1—renal system—prostate cancer	0.000224	0.00422	CbGeAlD
Liotrix—ABCB1—urethra—prostate cancer	0.00022	0.00415	CbGeAlD
Liotrix—ABCB1—bone marrow—prostate cancer	0.000169	0.00319	CbGeAlD
Liotrix—ABCB1—testis—prostate cancer	0.000145	0.00273	CbGeAlD
Liotrix—ABCB1—lymph node—prostate cancer	0.000105	0.00198	CbGeAlD
Liotrix—Paraesthesia—Etoposide—prostate cancer	5.09e-05	0.000285	CcSEcCtD
Liotrix—Loss of consciousness—Docetaxel—prostate cancer	5.07e-05	0.000284	CcSEcCtD
Liotrix—Weight decreased—Epirubicin—prostate cancer	5.06e-05	0.000283	CcSEcCtD
Liotrix—Dyspnoea—Etoposide—prostate cancer	5.05e-05	0.000283	CcSEcCtD
Liotrix—Alopecia—Prednisone—prostate cancer	5.05e-05	0.000283	CcSEcCtD
Liotrix—Angina pectoris—Doxorubicin—prostate cancer	5.04e-05	0.000282	CcSEcCtD
Liotrix—Hypersensitivity—Mitoxantrone—prostate cancer	5.02e-05	0.000281	CcSEcCtD
Liotrix—Syncope—Capecitabine—prostate cancer	5.01e-05	0.000281	CcSEcCtD
Liotrix—Diarrhoea—Estradiol—prostate cancer	5e-05	0.00028	CcSEcCtD
Liotrix—Convulsion—Docetaxel—prostate cancer	5e-05	0.00028	CcSEcCtD
Liotrix—Hypertension—Docetaxel—prostate cancer	4.98e-05	0.000279	CcSEcCtD
Liotrix—Bronchitis—Doxorubicin—prostate cancer	4.97e-05	0.000279	CcSEcCtD
Liotrix—Palpitations—Capecitabine—prostate cancer	4.94e-05	0.000277	CcSEcCtD
Liotrix—Decreased appetite—Etoposide—prostate cancer	4.93e-05	0.000276	CcSEcCtD
Liotrix—Arthralgia—Docetaxel—prostate cancer	4.91e-05	0.000275	CcSEcCtD
Liotrix—Chest pain—Docetaxel—prostate cancer	4.91e-05	0.000275	CcSEcCtD
Liotrix—Loss of consciousness—Capecitabine—prostate cancer	4.91e-05	0.000275	CcSEcCtD
Liotrix—Renal failure—Epirubicin—prostate cancer	4.9e-05	0.000275	CcSEcCtD
Liotrix—Asthenia—Mitoxantrone—prostate cancer	4.89e-05	0.000274	CcSEcCtD
Liotrix—Fatigue—Etoposide—prostate cancer	4.89e-05	0.000274	CcSEcCtD
Liotrix—Constipation—Etoposide—prostate cancer	4.85e-05	0.000272	CcSEcCtD
Liotrix—Dizziness—Estradiol—prostate cancer	4.84e-05	0.000271	CcSEcCtD
Liotrix—Hypertension—Capecitabine—prostate cancer	4.83e-05	0.00027	CcSEcCtD
Liotrix—Sweating—Epirubicin—prostate cancer	4.78e-05	0.000268	CcSEcCtD
Liotrix—Arthralgia—Capecitabine—prostate cancer	4.76e-05	0.000267	CcSEcCtD
Liotrix—Chest pain—Capecitabine—prostate cancer	4.76e-05	0.000267	CcSEcCtD
Liotrix—Confusional state—Docetaxel—prostate cancer	4.75e-05	0.000266	CcSEcCtD
Liotrix—Anxiety—Capecitabine—prostate cancer	4.74e-05	0.000266	CcSEcCtD
Liotrix—Oedema—Docetaxel—prostate cancer	4.71e-05	0.000264	CcSEcCtD
Liotrix—Anaphylactic shock—Docetaxel—prostate cancer	4.71e-05	0.000264	CcSEcCtD
Liotrix—Vision blurred—Prednisone—prostate cancer	4.69e-05	0.000263	CcSEcCtD
Liotrix—Infection—Docetaxel—prostate cancer	4.68e-05	0.000262	CcSEcCtD
Liotrix—Weight decreased—Doxorubicin—prostate cancer	4.68e-05	0.000262	CcSEcCtD
Liotrix—Feeling abnormal—Etoposide—prostate cancer	4.67e-05	0.000262	CcSEcCtD
Liotrix—Diarrhoea—Mitoxantrone—prostate cancer	4.66e-05	0.000261	CcSEcCtD
Liotrix—Vomiting—Estradiol—prostate cancer	4.65e-05	0.000261	CcSEcCtD
Liotrix—Gastrointestinal pain—Etoposide—prostate cancer	4.64e-05	0.00026	CcSEcCtD
Liotrix—Shock—Docetaxel—prostate cancer	4.64e-05	0.00026	CcSEcCtD
Liotrix—Rash—Estradiol—prostate cancer	4.61e-05	0.000258	CcSEcCtD
Liotrix—Dermatitis—Estradiol—prostate cancer	4.61e-05	0.000258	CcSEcCtD
Liotrix—Confusional state—Capecitabine—prostate cancer	4.6e-05	0.000258	CcSEcCtD
Liotrix—Tachycardia—Docetaxel—prostate cancer	4.6e-05	0.000258	CcSEcCtD
Liotrix—Headache—Estradiol—prostate cancer	4.58e-05	0.000257	CcSEcCtD
Liotrix—Agitation—Prednisone—prostate cancer	4.58e-05	0.000256	CcSEcCtD
Liotrix—Oedema—Capecitabine—prostate cancer	4.56e-05	0.000256	CcSEcCtD
Liotrix—Angioedema—Prednisone—prostate cancer	4.55e-05	0.000255	CcSEcCtD
Liotrix—Renal failure—Doxorubicin—prostate cancer	4.53e-05	0.000254	CcSEcCtD
Liotrix—Infection—Capecitabine—prostate cancer	4.53e-05	0.000254	CcSEcCtD
Liotrix—Urticaria—Etoposide—prostate cancer	4.5e-05	0.000252	CcSEcCtD
Liotrix—Anorexia—Docetaxel—prostate cancer	4.49e-05	0.000252	CcSEcCtD
Liotrix—Shock—Capecitabine—prostate cancer	4.49e-05	0.000252	CcSEcCtD
Liotrix—Abdominal pain—Etoposide—prostate cancer	4.48e-05	0.000251	CcSEcCtD
Liotrix—Body temperature increased—Etoposide—prostate cancer	4.48e-05	0.000251	CcSEcCtD
Liotrix—Syncope—Prednisone—prostate cancer	4.46e-05	0.00025	CcSEcCtD
Liotrix—Tachycardia—Capecitabine—prostate cancer	4.45e-05	0.00025	CcSEcCtD
Liotrix—Hypoaesthesia—Epirubicin—prostate cancer	4.45e-05	0.000249	CcSEcCtD
Liotrix—Sweating—Doxorubicin—prostate cancer	4.42e-05	0.000248	CcSEcCtD
Liotrix—Hyperhidrosis—Capecitabine—prostate cancer	4.41e-05	0.000247	CcSEcCtD
Liotrix—Hypotension—Docetaxel—prostate cancer	4.4e-05	0.000247	CcSEcCtD
Liotrix—Loss of consciousness—Prednisone—prostate cancer	4.38e-05	0.000245	CcSEcCtD
Liotrix—Anorexia—Capecitabine—prostate cancer	4.35e-05	0.000244	CcSEcCtD
Liotrix—Nausea—Estradiol—prostate cancer	4.34e-05	0.000244	CcSEcCtD
Liotrix—Vomiting—Mitoxantrone—prostate cancer	4.33e-05	0.000243	CcSEcCtD
Liotrix—Convulsion—Prednisone—prostate cancer	4.31e-05	0.000242	CcSEcCtD
Liotrix—Hypertension—Prednisone—prostate cancer	4.3e-05	0.000241	CcSEcCtD
Liotrix—Rash—Mitoxantrone—prostate cancer	4.3e-05	0.000241	CcSEcCtD
Liotrix—Dermatitis—Mitoxantrone—prostate cancer	4.29e-05	0.000241	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.29e-05	0.000241	CcSEcCtD
Liotrix—Headache—Mitoxantrone—prostate cancer	4.27e-05	0.000239	CcSEcCtD
Liotrix—Hypotension—Capecitabine—prostate cancer	4.26e-05	0.000239	CcSEcCtD
Liotrix—Insomnia—Docetaxel—prostate cancer	4.26e-05	0.000239	CcSEcCtD
Liotrix—Arthralgia—Prednisone—prostate cancer	4.24e-05	0.000238	CcSEcCtD
Liotrix—Paraesthesia—Docetaxel—prostate cancer	4.23e-05	0.000237	CcSEcCtD
Liotrix—Anxiety—Prednisone—prostate cancer	4.22e-05	0.000237	CcSEcCtD
Liotrix—Dyspnoea—Docetaxel—prostate cancer	4.2e-05	0.000235	CcSEcCtD
Liotrix—Hypersensitivity—Etoposide—prostate cancer	4.18e-05	0.000234	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.16e-05	0.000233	CcSEcCtD
Liotrix—Flushing—Epirubicin—prostate cancer	4.15e-05	0.000233	CcSEcCtD
Liotrix—Insomnia—Capecitabine—prostate cancer	4.13e-05	0.000231	CcSEcCtD
Liotrix—Hypoaesthesia—Doxorubicin—prostate cancer	4.12e-05	0.000231	CcSEcCtD
Liotrix—Paraesthesia—Capecitabine—prostate cancer	4.1e-05	0.00023	CcSEcCtD
Liotrix—Decreased appetite—Docetaxel—prostate cancer	4.1e-05	0.00023	CcSEcCtD
Liotrix—Asthenia—Etoposide—prostate cancer	4.07e-05	0.000228	CcSEcCtD
Liotrix—Dyspnoea—Capecitabine—prostate cancer	4.07e-05	0.000228	CcSEcCtD
Liotrix—Oedema—Prednisone—prostate cancer	4.06e-05	0.000228	CcSEcCtD
Liotrix—Anaphylactic shock—Prednisone—prostate cancer	4.06e-05	0.000228	CcSEcCtD
Liotrix—Fatigue—Docetaxel—prostate cancer	4.06e-05	0.000228	CcSEcCtD
Liotrix—Nausea—Mitoxantrone—prostate cancer	4.05e-05	0.000227	CcSEcCtD
Liotrix—Infection—Prednisone—prostate cancer	4.04e-05	0.000226	CcSEcCtD
Liotrix—Constipation—Docetaxel—prostate cancer	4.03e-05	0.000226	CcSEcCtD
Liotrix—Pruritus—Etoposide—prostate cancer	4.01e-05	0.000225	CcSEcCtD
Liotrix—Shock—Prednisone—prostate cancer	4e-05	0.000224	CcSEcCtD
Liotrix—Arrhythmia—Epirubicin—prostate cancer	4e-05	0.000224	CcSEcCtD
Liotrix—Tachycardia—Prednisone—prostate cancer	3.97e-05	0.000222	CcSEcCtD
Liotrix—Decreased appetite—Capecitabine—prostate cancer	3.97e-05	0.000222	CcSEcCtD
Liotrix—Alopecia—Epirubicin—prostate cancer	3.95e-05	0.000222	CcSEcCtD
Liotrix—Fatigue—Capecitabine—prostate cancer	3.93e-05	0.00022	CcSEcCtD
Liotrix—Hyperhidrosis—Prednisone—prostate cancer	3.93e-05	0.00022	CcSEcCtD
Liotrix—Constipation—Capecitabine—prostate cancer	3.9e-05	0.000219	CcSEcCtD
Liotrix—Feeling abnormal—Docetaxel—prostate cancer	3.88e-05	0.000218	CcSEcCtD
Liotrix—Diarrhoea—Etoposide—prostate cancer	3.88e-05	0.000217	CcSEcCtD
Liotrix—Anorexia—Prednisone—prostate cancer	3.87e-05	0.000217	CcSEcCtD
Liotrix—Gastrointestinal pain—Docetaxel—prostate cancer	3.85e-05	0.000216	CcSEcCtD
Liotrix—Flushing—Doxorubicin—prostate cancer	3.84e-05	0.000215	CcSEcCtD
Liotrix—Flatulence—Epirubicin—prostate cancer	3.84e-05	0.000215	CcSEcCtD
Liotrix—Tension—Epirubicin—prostate cancer	3.82e-05	0.000214	CcSEcCtD
Liotrix—Dysgeusia—Epirubicin—prostate cancer	3.81e-05	0.000214	CcSEcCtD
Liotrix—Nervousness—Epirubicin—prostate cancer	3.78e-05	0.000212	CcSEcCtD
Liotrix—Feeling abnormal—Capecitabine—prostate cancer	3.76e-05	0.000211	CcSEcCtD
Liotrix—Dizziness—Etoposide—prostate cancer	3.75e-05	0.00021	CcSEcCtD
Liotrix—Gastrointestinal pain—Capecitabine—prostate cancer	3.73e-05	0.000209	CcSEcCtD
Liotrix—Body temperature increased—Docetaxel—prostate cancer	3.72e-05	0.000209	CcSEcCtD
Liotrix—Abdominal pain—Docetaxel—prostate cancer	3.72e-05	0.000209	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Prednisone—prostate cancer	3.7e-05	0.000207	CcSEcCtD
Liotrix—Arrhythmia—Doxorubicin—prostate cancer	3.7e-05	0.000207	CcSEcCtD
Liotrix—Insomnia—Prednisone—prostate cancer	3.68e-05	0.000206	CcSEcCtD
Liotrix—Vision blurred—Epirubicin—prostate cancer	3.67e-05	0.000206	CcSEcCtD
Liotrix—Alopecia—Doxorubicin—prostate cancer	3.66e-05	0.000205	CcSEcCtD
Liotrix—Paraesthesia—Prednisone—prostate cancer	3.65e-05	0.000204	CcSEcCtD
Liotrix—Urticaria—Capecitabine—prostate cancer	3.62e-05	0.000203	CcSEcCtD
Liotrix—Abdominal pain—Capecitabine—prostate cancer	3.61e-05	0.000202	CcSEcCtD
Liotrix—Body temperature increased—Capecitabine—prostate cancer	3.61e-05	0.000202	CcSEcCtD
Liotrix—Vomiting—Etoposide—prostate cancer	3.6e-05	0.000202	CcSEcCtD
Liotrix—Agitation—Epirubicin—prostate cancer	3.58e-05	0.000201	CcSEcCtD
Liotrix—Rash—Etoposide—prostate cancer	3.57e-05	0.0002	CcSEcCtD
Liotrix—Dermatitis—Etoposide—prostate cancer	3.57e-05	0.0002	CcSEcCtD
Liotrix—Headache—Etoposide—prostate cancer	3.55e-05	0.000199	CcSEcCtD
Liotrix—Flatulence—Doxorubicin—prostate cancer	3.55e-05	0.000199	CcSEcCtD
Liotrix—Tension—Doxorubicin—prostate cancer	3.54e-05	0.000198	CcSEcCtD
Liotrix—Decreased appetite—Prednisone—prostate cancer	3.53e-05	0.000198	CcSEcCtD
Liotrix—Dysgeusia—Doxorubicin—prostate cancer	3.53e-05	0.000198	CcSEcCtD
Liotrix—Fatigue—Prednisone—prostate cancer	3.5e-05	0.000196	CcSEcCtD
Liotrix—Nervousness—Doxorubicin—prostate cancer	3.5e-05	0.000196	CcSEcCtD
Liotrix—Syncope—Epirubicin—prostate cancer	3.49e-05	0.000196	CcSEcCtD
Liotrix—Constipation—Prednisone—prostate cancer	3.47e-05	0.000195	CcSEcCtD
Liotrix—Hypersensitivity—Docetaxel—prostate cancer	3.47e-05	0.000195	CcSEcCtD
Liotrix—Palpitations—Epirubicin—prostate cancer	3.44e-05	0.000193	CcSEcCtD
Liotrix—Loss of consciousness—Epirubicin—prostate cancer	3.42e-05	0.000192	CcSEcCtD
Liotrix—Vision blurred—Doxorubicin—prostate cancer	3.4e-05	0.00019	CcSEcCtD
Liotrix—Asthenia—Docetaxel—prostate cancer	3.38e-05	0.000189	CcSEcCtD
Liotrix—Convulsion—Epirubicin—prostate cancer	3.37e-05	0.000189	CcSEcCtD
Liotrix—Nausea—Etoposide—prostate cancer	3.37e-05	0.000189	CcSEcCtD
Liotrix—Hypertension—Epirubicin—prostate cancer	3.36e-05	0.000188	CcSEcCtD
Liotrix—Hypersensitivity—Capecitabine—prostate cancer	3.36e-05	0.000188	CcSEcCtD
Liotrix—Feeling abnormal—Prednisone—prostate cancer	3.35e-05	0.000188	CcSEcCtD
Liotrix—Pruritus—Docetaxel—prostate cancer	3.33e-05	0.000187	CcSEcCtD
Liotrix—Gastrointestinal pain—Prednisone—prostate cancer	3.32e-05	0.000186	CcSEcCtD
Liotrix—Chest pain—Epirubicin—prostate cancer	3.32e-05	0.000186	CcSEcCtD
Liotrix—Arthralgia—Epirubicin—prostate cancer	3.32e-05	0.000186	CcSEcCtD
Liotrix—Agitation—Doxorubicin—prostate cancer	3.31e-05	0.000186	CcSEcCtD
Liotrix—Anxiety—Epirubicin—prostate cancer	3.3e-05	0.000185	CcSEcCtD
Liotrix—Asthenia—Capecitabine—prostate cancer	3.27e-05	0.000183	CcSEcCtD
Liotrix—Syncope—Doxorubicin—prostate cancer	3.23e-05	0.000181	CcSEcCtD
Liotrix—Urticaria—Prednisone—prostate cancer	3.23e-05	0.000181	CcSEcCtD
Liotrix—Pruritus—Capecitabine—prostate cancer	3.23e-05	0.000181	CcSEcCtD
Liotrix—Diarrhoea—Docetaxel—prostate cancer	3.22e-05	0.000181	CcSEcCtD
Liotrix—Abdominal pain—Prednisone—prostate cancer	3.21e-05	0.00018	CcSEcCtD
Liotrix—Body temperature increased—Prednisone—prostate cancer	3.21e-05	0.00018	CcSEcCtD
Liotrix—Confusional state—Epirubicin—prostate cancer	3.2e-05	0.00018	CcSEcCtD
Liotrix—Palpitations—Doxorubicin—prostate cancer	3.18e-05	0.000178	CcSEcCtD
Liotrix—Oedema—Epirubicin—prostate cancer	3.18e-05	0.000178	CcSEcCtD
Liotrix—Anaphylactic shock—Epirubicin—prostate cancer	3.18e-05	0.000178	CcSEcCtD
Liotrix—Loss of consciousness—Doxorubicin—prostate cancer	3.17e-05	0.000177	CcSEcCtD
Liotrix—Infection—Epirubicin—prostate cancer	3.16e-05	0.000177	CcSEcCtD
Liotrix—Shock—Epirubicin—prostate cancer	3.13e-05	0.000175	CcSEcCtD
Liotrix—Convulsion—Doxorubicin—prostate cancer	3.12e-05	0.000175	CcSEcCtD
Liotrix—Diarrhoea—Capecitabine—prostate cancer	3.12e-05	0.000175	CcSEcCtD
Liotrix—Dizziness—Docetaxel—prostate cancer	3.12e-05	0.000175	CcSEcCtD
Liotrix—Hypertension—Doxorubicin—prostate cancer	3.11e-05	0.000174	CcSEcCtD
Liotrix—Tachycardia—Epirubicin—prostate cancer	3.1e-05	0.000174	CcSEcCtD
Liotrix—Hyperhidrosis—Epirubicin—prostate cancer	3.07e-05	0.000172	CcSEcCtD
Liotrix—Chest pain—Doxorubicin—prostate cancer	3.07e-05	0.000172	CcSEcCtD
Liotrix—Arthralgia—Doxorubicin—prostate cancer	3.07e-05	0.000172	CcSEcCtD
Liotrix—Anxiety—Doxorubicin—prostate cancer	3.06e-05	0.000171	CcSEcCtD
Liotrix—Anorexia—Epirubicin—prostate cancer	3.03e-05	0.00017	CcSEcCtD
Liotrix—Dizziness—Capecitabine—prostate cancer	3.02e-05	0.000169	CcSEcCtD
Liotrix—Vomiting—Docetaxel—prostate cancer	3e-05	0.000168	CcSEcCtD
Liotrix—Hypersensitivity—Prednisone—prostate cancer	2.99e-05	0.000168	CcSEcCtD
Liotrix—Rash—Docetaxel—prostate cancer	2.97e-05	0.000166	CcSEcCtD
Liotrix—Hypotension—Epirubicin—prostate cancer	2.97e-05	0.000166	CcSEcCtD
Liotrix—Dermatitis—Docetaxel—prostate cancer	2.97e-05	0.000166	CcSEcCtD
Liotrix—Confusional state—Doxorubicin—prostate cancer	2.96e-05	0.000166	CcSEcCtD
Liotrix—Headache—Docetaxel—prostate cancer	2.95e-05	0.000165	CcSEcCtD
Liotrix—Oedema—Doxorubicin—prostate cancer	2.94e-05	0.000165	CcSEcCtD
Liotrix—Anaphylactic shock—Doxorubicin—prostate cancer	2.94e-05	0.000165	CcSEcCtD
Liotrix—Infection—Doxorubicin—prostate cancer	2.92e-05	0.000164	CcSEcCtD
Liotrix—Asthenia—Prednisone—prostate cancer	2.92e-05	0.000163	CcSEcCtD
Liotrix—Vomiting—Capecitabine—prostate cancer	2.9e-05	0.000163	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.9e-05	0.000162	CcSEcCtD
Liotrix—Shock—Doxorubicin—prostate cancer	2.89e-05	0.000162	CcSEcCtD
Liotrix—Rash—Capecitabine—prostate cancer	2.88e-05	0.000161	CcSEcCtD
Liotrix—Pruritus—Prednisone—prostate cancer	2.87e-05	0.000161	CcSEcCtD
Liotrix—Insomnia—Epirubicin—prostate cancer	2.87e-05	0.000161	CcSEcCtD
Liotrix—Dermatitis—Capecitabine—prostate cancer	2.87e-05	0.000161	CcSEcCtD
Liotrix—Tachycardia—Doxorubicin—prostate cancer	2.87e-05	0.000161	CcSEcCtD
Liotrix—Headache—Capecitabine—prostate cancer	2.86e-05	0.00016	CcSEcCtD
Liotrix—Paraesthesia—Epirubicin—prostate cancer	2.85e-05	0.00016	CcSEcCtD
Liotrix—Hyperhidrosis—Doxorubicin—prostate cancer	2.84e-05	0.000159	CcSEcCtD
Liotrix—Dyspnoea—Epirubicin—prostate cancer	2.83e-05	0.000159	CcSEcCtD
Liotrix—Anorexia—Doxorubicin—prostate cancer	2.8e-05	0.000157	CcSEcCtD
Liotrix—Nausea—Docetaxel—prostate cancer	2.8e-05	0.000157	CcSEcCtD
Liotrix—Diarrhoea—Prednisone—prostate cancer	2.78e-05	0.000156	CcSEcCtD
Liotrix—Decreased appetite—Epirubicin—prostate cancer	2.76e-05	0.000155	CcSEcCtD
Liotrix—Hypotension—Doxorubicin—prostate cancer	2.75e-05	0.000154	CcSEcCtD
Liotrix—Fatigue—Epirubicin—prostate cancer	2.74e-05	0.000154	CcSEcCtD
Liotrix—Constipation—Epirubicin—prostate cancer	2.72e-05	0.000152	CcSEcCtD
Liotrix—Nausea—Capecitabine—prostate cancer	2.71e-05	0.000152	CcSEcCtD
Liotrix—Dizziness—Prednisone—prostate cancer	2.69e-05	0.000151	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.68e-05	0.00015	CcSEcCtD
Liotrix—Insomnia—Doxorubicin—prostate cancer	2.66e-05	0.000149	CcSEcCtD
Liotrix—Paraesthesia—Doxorubicin—prostate cancer	2.64e-05	0.000148	CcSEcCtD
Liotrix—Dyspnoea—Doxorubicin—prostate cancer	2.62e-05	0.000147	CcSEcCtD
Liotrix—Feeling abnormal—Epirubicin—prostate cancer	2.62e-05	0.000147	CcSEcCtD
Liotrix—Gastrointestinal pain—Epirubicin—prostate cancer	2.6e-05	0.000146	CcSEcCtD
Liotrix—Vomiting—Prednisone—prostate cancer	2.58e-05	0.000145	CcSEcCtD
Liotrix—Rash—Prednisone—prostate cancer	2.56e-05	0.000144	CcSEcCtD
Liotrix—Dermatitis—Prednisone—prostate cancer	2.56e-05	0.000143	CcSEcCtD
Liotrix—Decreased appetite—Doxorubicin—prostate cancer	2.56e-05	0.000143	CcSEcCtD
Liotrix—Headache—Prednisone—prostate cancer	2.55e-05	0.000143	CcSEcCtD
Liotrix—Fatigue—Doxorubicin—prostate cancer	2.54e-05	0.000142	CcSEcCtD
Liotrix—Urticaria—Epirubicin—prostate cancer	2.52e-05	0.000141	CcSEcCtD
Liotrix—Constipation—Doxorubicin—prostate cancer	2.51e-05	0.000141	CcSEcCtD
Liotrix—Abdominal pain—Epirubicin—prostate cancer	2.51e-05	0.000141	CcSEcCtD
Liotrix—Body temperature increased—Epirubicin—prostate cancer	2.51e-05	0.000141	CcSEcCtD
Liotrix—Feeling abnormal—Doxorubicin—prostate cancer	2.42e-05	0.000136	CcSEcCtD
Liotrix—Nausea—Prednisone—prostate cancer	2.41e-05	0.000135	CcSEcCtD
Liotrix—Gastrointestinal pain—Doxorubicin—prostate cancer	2.4e-05	0.000135	CcSEcCtD
Liotrix—Hypersensitivity—Epirubicin—prostate cancer	2.34e-05	0.000131	CcSEcCtD
Liotrix—Urticaria—Doxorubicin—prostate cancer	2.34e-05	0.000131	CcSEcCtD
Liotrix—Abdominal pain—Doxorubicin—prostate cancer	2.32e-05	0.00013	CcSEcCtD
Liotrix—Body temperature increased—Doxorubicin—prostate cancer	2.32e-05	0.00013	CcSEcCtD
Liotrix—Asthenia—Epirubicin—prostate cancer	2.28e-05	0.000128	CcSEcCtD
Liotrix—Pruritus—Epirubicin—prostate cancer	2.25e-05	0.000126	CcSEcCtD
Liotrix—Diarrhoea—Epirubicin—prostate cancer	2.17e-05	0.000122	CcSEcCtD
Liotrix—Hypersensitivity—Doxorubicin—prostate cancer	2.17e-05	0.000121	CcSEcCtD
Liotrix—Asthenia—Doxorubicin—prostate cancer	2.11e-05	0.000118	CcSEcCtD
Liotrix—Dizziness—Epirubicin—prostate cancer	2.1e-05	0.000118	CcSEcCtD
Liotrix—Pruritus—Doxorubicin—prostate cancer	2.08e-05	0.000117	CcSEcCtD
Liotrix—Vomiting—Epirubicin—prostate cancer	2.02e-05	0.000113	CcSEcCtD
Liotrix—Diarrhoea—Doxorubicin—prostate cancer	2.01e-05	0.000113	CcSEcCtD
Liotrix—Rash—Epirubicin—prostate cancer	2e-05	0.000112	CcSEcCtD
Liotrix—Dermatitis—Epirubicin—prostate cancer	2e-05	0.000112	CcSEcCtD
Liotrix—Headache—Epirubicin—prostate cancer	1.99e-05	0.000112	CcSEcCtD
Liotrix—Dizziness—Doxorubicin—prostate cancer	1.94e-05	0.000109	CcSEcCtD
Liotrix—Nausea—Epirubicin—prostate cancer	1.89e-05	0.000106	CcSEcCtD
Liotrix—Vomiting—Doxorubicin—prostate cancer	1.87e-05	0.000105	CcSEcCtD
Liotrix—Rash—Doxorubicin—prostate cancer	1.85e-05	0.000104	CcSEcCtD
Liotrix—Dermatitis—Doxorubicin—prostate cancer	1.85e-05	0.000104	CcSEcCtD
Liotrix—Headache—Doxorubicin—prostate cancer	1.84e-05	0.000103	CcSEcCtD
Liotrix—Nausea—Doxorubicin—prostate cancer	1.75e-05	9.79e-05	CcSEcCtD
Liotrix—SLCO1A2—Metabolism—MTHFR—prostate cancer	4.41e-06	4.46e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SULT2A1—prostate cancer	4.4e-06	4.45e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTA1—prostate cancer	4.37e-06	4.43e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CREBBP—prostate cancer	4.37e-06	4.42e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCND1—prostate cancer	4.37e-06	4.42e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—MED12—prostate cancer	4.35e-06	4.4e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	4.33e-06	4.39e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—MED12—prostate cancer	4.33e-06	4.38e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PPARA—prostate cancer	4.32e-06	4.38e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CTNNB1—prostate cancer	4.32e-06	4.38e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTO1—prostate cancer	4.32e-06	4.38e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HSD3B2—prostate cancer	4.32e-06	4.38e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NAT2—prostate cancer	4.32e-06	4.38e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GNG5—prostate cancer	4.32e-06	4.37e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TYMS—prostate cancer	4.31e-06	4.37e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GNG5—prostate cancer	4.29e-06	4.34e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTM1—prostate cancer	4.26e-06	4.32e-05	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CA—prostate cancer	4.25e-06	4.3e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—prostate cancer	4.24e-06	4.29e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1A—prostate cancer	4.22e-06	4.28e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTEN—prostate cancer	4.21e-06	4.27e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—LPL—prostate cancer	4.19e-06	4.24e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOA3—prostate cancer	4.16e-06	4.21e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—LRP2—prostate cancer	4.14e-06	4.2e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PLCB2—prostate cancer	4.14e-06	4.2e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP2C18—prostate cancer	4.14e-06	4.2e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CD—prostate cancer	4.14e-06	4.19e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CREBBP—prostate cancer	4.14e-06	4.19e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOA3—prostate cancer	4.13e-06	4.19e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.09e-06	4.14e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IGF1—prostate cancer	4.09e-06	4.14e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CAV1—prostate cancer	4.07e-06	4.12e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—P4HB—prostate cancer	4.06e-06	4.11e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.06e-06	4.11e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	4.04e-06	4.09e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP1A1—prostate cancer	4.04e-06	4.09e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EP300—prostate cancer	4.02e-06	4.07e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ERCC2—prostate cancer	4.01e-06	4.06e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	3.98e-06	4.03e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HPGDS—prostate cancer	3.97e-06	4.02e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC22A1—prostate cancer	3.95e-06	4e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.95e-06	4e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HPGDS—prostate cancer	3.94e-06	3.99e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP2C19—prostate cancer	3.94e-06	3.99e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CD—prostate cancer	3.92e-06	3.97e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP2C19—prostate cancer	3.92e-06	3.97e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—NOS3—prostate cancer	3.91e-06	3.96e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SRC—prostate cancer	3.91e-06	3.96e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.88e-06	3.93e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SERPINE1—prostate cancer	3.88e-06	3.93e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SULT2A1—prostate cancer	3.85e-06	3.9e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	3.85e-06	3.9e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ACHE—prostate cancer	3.85e-06	3.89e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTT1—prostate cancer	3.85e-06	3.89e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTT1—prostate cancer	3.83e-06	3.87e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ACHE—prostate cancer	3.83e-06	3.87e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—prostate cancer	3.81e-06	3.85e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP2A6—prostate cancer	3.8e-06	3.85e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MED12—prostate cancer	3.79e-06	3.84e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.79e-06	3.83e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP2A6—prostate cancer	3.78e-06	3.83e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—MTHFR—prostate cancer	3.77e-06	3.82e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—STAT3—prostate cancer	3.77e-06	3.82e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.77e-06	3.81e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GNG5—prostate cancer	3.76e-06	3.81e-05	CbGpPWpGaD
Liotrix—TTR—Disease—IL6—prostate cancer	3.76e-06	3.81e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS3—prostate cancer	3.7e-06	3.75e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CG—prostate cancer	3.7e-06	3.75e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKR1C3—prostate cancer	3.7e-06	3.74e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PPARA—prostate cancer	3.7e-06	3.74e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PRKACB—prostate cancer	3.68e-06	3.73e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKR1C3—prostate cancer	3.68e-06	3.72e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PRKACB—prostate cancer	3.66e-06	3.7e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP17A1—prostate cancer	3.64e-06	3.69e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOA3—prostate cancer	3.62e-06	3.67e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP17A1—prostate cancer	3.62e-06	3.67e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CB—prostate cancer	3.61e-06	3.66e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—JAK2—prostate cancer	3.6e-06	3.64e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.59e-06	3.64e-05	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.58e-06	3.63e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—prostate cancer	3.58e-06	3.62e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.57e-06	3.62e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CA—prostate cancer	3.52e-06	3.56e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—INS—prostate cancer	3.51e-06	3.55e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MYC—prostate cancer	3.5e-06	3.55e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TGFB1—prostate cancer	3.49e-06	3.54e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CAV1—prostate cancer	3.48e-06	3.52e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOA2—prostate cancer	3.47e-06	3.51e-05	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—prostate cancer	3.47e-06	3.51e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HPGDS—prostate cancer	3.46e-06	3.5e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOA2—prostate cancer	3.45e-06	3.49e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP2C19—prostate cancer	3.43e-06	3.48e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CREBBP—prostate cancer	3.43e-06	3.48e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—prostate cancer	3.43e-06	3.47e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CB—prostate cancer	3.42e-06	3.46e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ACHE—prostate cancer	3.35e-06	3.39e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTT1—prostate cancer	3.35e-06	3.39e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.32e-06	3.36e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP2A6—prostate cancer	3.31e-06	3.35e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC5A5—prostate cancer	3.31e-06	3.35e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	3.3e-06	3.34e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC5A5—prostate cancer	3.29e-06	3.33e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CD—prostate cancer	3.26e-06	3.3e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	3.25e-06	3.29e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KRAS—prostate cancer	3.24e-06	3.28e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP2E1—prostate cancer	3.23e-06	3.27e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKR1C3—prostate cancer	3.22e-06	3.26e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP2E1—prostate cancer	3.21e-06	3.25e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PRKACB—prostate cancer	3.21e-06	3.25e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NQO1—prostate cancer	3.2e-06	3.24e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NQO1—prostate cancer	3.18e-06	3.22e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP17A1—prostate cancer	3.17e-06	3.21e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CG—prostate cancer	3.17e-06	3.21e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TH—prostate cancer	3.15e-06	3.19e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL2—prostate cancer	3.14e-06	3.18e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.14e-06	3.18e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—TH—prostate cancer	3.13e-06	3.17e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.13e-06	3.17e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTEN—prostate cancer	3.12e-06	3.16e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP3A4—prostate cancer	3.12e-06	3.16e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.11e-06	3.15e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.1e-06	3.14e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP3A4—prostate cancer	3.1e-06	3.14e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.08e-06	3.12e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NOS3—prostate cancer	3.07e-06	3.11e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP1B1—prostate cancer	3.07e-06	3.1e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP1B1—prostate cancer	3.05e-06	3.09e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOA2—prostate cancer	3.02e-06	3.06e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—INS—prostate cancer	3e-06	3.03e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—EP300—prostate cancer	2.98e-06	3.01e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CA—prostate cancer	2.97e-06	3.01e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GGT1—prostate cancer	2.97e-06	3.01e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GGT1—prostate cancer	2.95e-06	2.99e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CREBBP—prostate cancer	2.94e-06	2.97e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOA1—prostate cancer	2.92e-06	2.96e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOA1—prostate cancer	2.91e-06	2.94e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC5A5—prostate cancer	2.88e-06	2.92e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP19A1—prostate cancer	2.88e-06	2.92e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—prostate cancer	2.88e-06	2.91e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—prostate cancer	2.87e-06	2.91e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP19A1—prostate cancer	2.87e-06	2.9e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CB—prostate cancer	2.84e-06	2.87e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—EP300—prostate cancer	2.82e-06	2.85e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP2E1—prostate cancer	2.82e-06	2.85e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—prostate cancer	2.81e-06	2.85e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NQO1—prostate cancer	2.79e-06	2.82e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CD—prostate cancer	2.78e-06	2.82e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—RXRA—prostate cancer	2.78e-06	2.82e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—RXRA—prostate cancer	2.77e-06	2.8e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TH—prostate cancer	2.75e-06	2.78e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SRC—prostate cancer	2.74e-06	2.77e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP3A4—prostate cancer	2.72e-06	2.75e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.71e-06	2.74e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.69e-06	2.72e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—COMT—prostate cancer	2.68e-06	2.71e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP1B1—prostate cancer	2.67e-06	2.7e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—prostate cancer	2.67e-06	2.7e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTP1—prostate cancer	2.67e-06	2.7e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—COMT—prostate cancer	2.66e-06	2.7e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTP1—prostate cancer	2.65e-06	2.68e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6—prostate cancer	2.63e-06	2.66e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NOS3—prostate cancer	2.63e-06	2.66e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ITPR1—prostate cancer	2.62e-06	2.66e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ITPR1—prostate cancer	2.61e-06	2.64e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GGT1—prostate cancer	2.59e-06	2.62e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.58e-06	2.61e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.57e-06	2.6e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOA1—prostate cancer	2.55e-06	2.58e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP19A1—prostate cancer	2.51e-06	2.54e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TYMS—prostate cancer	2.48e-06	2.51e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—TYMS—prostate cancer	2.46e-06	2.5e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTEN—prostate cancer	2.45e-06	2.48e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTM1—prostate cancer	2.45e-06	2.48e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TGFB1—prostate cancer	2.45e-06	2.48e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTM1—prostate cancer	2.44e-06	2.47e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—prostate cancer	2.43e-06	2.46e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CB—prostate cancer	2.43e-06	2.46e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—RXRA—prostate cancer	2.42e-06	2.45e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—LPL—prostate cancer	2.41e-06	2.43e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—prostate cancer	2.4e-06	2.43e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—LPL—prostate cancer	2.39e-06	2.42e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—EP300—prostate cancer	2.34e-06	2.37e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—COMT—prostate cancer	2.33e-06	2.36e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTP1—prostate cancer	2.32e-06	2.35e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.32e-06	2.35e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP1A1—prostate cancer	2.31e-06	2.34e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ERCC2—prostate cancer	2.3e-06	2.33e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ERCC2—prostate cancer	2.29e-06	2.32e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ITPR1—prostate cancer	2.29e-06	2.31e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KRAS—prostate cancer	2.27e-06	2.3e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CA—prostate cancer	2.2e-06	2.23e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—MTHFR—prostate cancer	2.17e-06	2.19e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TYMS—prostate cancer	2.16e-06	2.19e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—MTHFR—prostate cancer	2.15e-06	2.18e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTM1—prostate cancer	2.13e-06	2.16e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPARA—prostate cancer	2.12e-06	2.15e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPARA—prostate cancer	2.11e-06	2.14e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTEN—prostate cancer	2.1e-06	2.12e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—LPL—prostate cancer	2.1e-06	2.12e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CA—prostate cancer	2.08e-06	2.11e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP1A1—prostate cancer	2.02e-06	2.05e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—prostate cancer	2.02e-06	2.04e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ERCC2—prostate cancer	2.01e-06	2.03e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—EP300—prostate cancer	2e-06	2.02e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CAV1—prostate cancer	2e-06	2.02e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CAV1—prostate cancer	1.99e-06	2.01e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.91e-06	1.93e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.9e-06	1.92e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MTHFR—prostate cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPARA—prostate cancer	1.85e-06	1.87e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.82e-06	1.84e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CG—prostate cancer	1.81e-06	1.83e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—prostate cancer	1.8e-06	1.82e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CAV1—prostate cancer	1.74e-06	1.76e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CA—prostate cancer	1.73e-06	1.75e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—INS—prostate cancer	1.72e-06	1.74e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—INS—prostate cancer	1.71e-06	1.73e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—prostate cancer	1.7e-06	1.72e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CREBBP—prostate cancer	1.69e-06	1.71e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CREBBP—prostate cancer	1.68e-06	1.7e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.6e-06	1.62e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CD—prostate cancer	1.59e-06	1.61e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CG—prostate cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NOS3—prostate cancer	1.51e-06	1.53e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NOS3—prostate cancer	1.5e-06	1.52e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—INS—prostate cancer	1.5e-06	1.52e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CA—prostate cancer	1.48e-06	1.5e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CREBBP—prostate cancer	1.47e-06	1.49e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—prostate cancer	1.41e-06	1.43e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.39e-06	1.41e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CD—prostate cancer	1.39e-06	1.41e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CB—prostate cancer	1.39e-06	1.4e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—prostate cancer	1.38e-06	1.4e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—prostate cancer	1.37e-06	1.39e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NOS3—prostate cancer	1.32e-06	1.33e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CB—prostate cancer	1.21e-06	1.23e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—prostate cancer	1.21e-06	1.22e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTEN—prostate cancer	1.2e-06	1.22e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—prostate cancer	1.2e-06	1.22e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTEN—prostate cancer	1.2e-06	1.21e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—EP300—prostate cancer	1.15e-06	1.16e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—EP300—prostate cancer	1.14e-06	1.16e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTEN—prostate cancer	1.05e-06	1.06e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—EP300—prostate cancer	1e-06	1.01e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CA—prostate cancer	8.5e-07	8.6e-06	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CA—prostate cancer	8.45e-07	8.56e-06	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CA—prostate cancer	7.4e-07	7.5e-06	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—prostate cancer	6.94e-07	7.03e-06	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—prostate cancer	6.9e-07	6.99e-06	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—prostate cancer	6.05e-07	6.12e-06	CbGpPWpGaD
